EGFR and hepatocellular carcinoma: The current study aimed to investigate the expression levels of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 in HCC cases by conventional immunohistochemistry (IHC) methods and assessed correlations among staining intensities, clinicopathologic features, and survival rates in 50 patients who underwent liver resections to treat HCC.